Does DABRAFENIB Cause Hepatic neoplasm? 9 Reports in FDA Database

Q: Does DABRAFENIB cause Hepatic neoplasm?

9 reports of Hepatic neoplasm have been filed with the FDA for DABRAFENIB, representing 0.1% of all DABRAFENIB adverse event reports.

Q: How dangerous is Hepatic neoplasm from DABRAFENIB?

Of 9 reports, 1 (11.1%) resulted in death and 9 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Hepatic neoplasm have been filed in association with DABRAFENIB (Tafinlar). This represents 0.1% of all adverse event reports for DABRAFENIB.

Reports of Hepatic neoplasm with DABRAFENIB

0.1%

of all DABRAFENIB reports

Deaths

Hospitalizations

How Dangerous Is Hepatic neoplasm From DABRAFENIB?

Of the 9 reports, 1 (11.1%) resulted in death, 9 (100.0%) required hospitalization.

Is Hepatic neoplasm Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DABRAFENIB. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does DABRAFENIB Cause?

Pyrexia (3,788) Death (2,740) Malignant neoplasm progression (1,667) Fatigue (1,328) Nausea (1,300) Chills (1,235) Rash (1,078) Vomiting (907) Diarrhoea (901) Headache (697)

What Other Drugs Cause Hepatic neoplasm?

OCTREOTIDE (300) ADALIMUMAB (98) LANREOTIDE (85) EVEROLIMUS (84) AMLODIPINE (74) ROSUVASTATIN (55) IMATINIB (51) BEVACIZUMAB (49) RIBAVIRIN (49) METFORMIN (47)

Which DABRAFENIB Alternatives Have Lower Hepatic neoplasm Risk?

DABRAFENIB vs DABRAFENIB\TRAMETINIB DABRAFENIB vs DACARBAZINE DABRAFENIB vs DACLATASVIR DABRAFENIB vs DACLIZUMAB DABRAFENIB vs DACOMITINIB

DABRAFENIB Full Profile All Hepatic neoplasm Reports All Drugs Causing Hepatic neoplasm DABRAFENIB Demographics